Intracellular concentrations of micafungin in different cellular compartments of the peripheral blood

Fedja Farowski1, Oliver A Cornely, Jörg J Vehreschild

  • 1Universitätsklinikum Köln, Klinik I für Innere Medizin, Köln, Germany. Fedja.Farowski@ctuc.de

Insights

Micafungin concentrates significantly within peripheral blood mononuclear cells (PBMCs) and polymorphonuclear leukocytes (PMNs), but not red blood cells (RBCs), in patients. This antifungal drug achieves high intracellular levels in key immune cells.

Area of Science:

  • Pharmacokinetics
  • Cellular Biology
  • Infectious Diseases

Background:

  • Micafungin is an echinocandin antifungal agent.
  • Serum concentrations of micafungin are well-documented.
  • Limited data exist on micafungin's intracellular distribution in peripheral blood cells.

Purpose of the Study:

  • To quantify intracellular micafungin concentrations in peripheral blood cells.
  • To compare intracellular concentrations with plasma levels.
  • To investigate factors influencing micafungin uptake in peripheral blood mononuclear cells (PBMCs).

Main Methods:

  • Blood samples were collected from 26 patients receiving micafungin.
  • Peripheral blood mononuclear cells (PBMCs), polymorphonuclear leukocytes (PMNs), and red blood cells (RBCs) were isolated using Ficoll-Hypaque density gradient centrifugation.
  • Intracellular micafungin concentrations were measured using liquid chromatography-tandem mass spectrometry (LC-MS/MS).

Main Results:

  • Intracellular micafungin concentrations were significantly higher in PBMCs and PMNs compared to plasma (P<0.001).
  • Intracellular micafungin concentrations in RBCs did not differ significantly from plasma concentrations.
  • In vitro studies indicated that albumin concentration affects PBMC uptake, but only at non-physiological levels.

Conclusions:

  • Micafungin achieves substantial intracellular concentrations in human PBMCs and PMNs.
  • Micafungin is present within RBCs, though not at elevated levels compared to plasma.
  • The uptake of micafungin into PBMCs is influenced by albumin, particularly under non-physiological conditions, suggesting potential implications for drug distribution.

Related Concept Videos

Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Drug Concentrations: Measurements01:23

Drug Concentrations: Measurements

Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma —...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...